Elanco Animal Health (ELAN) Shares Outstanding (2017 - 2026)

Elanco Animal Health has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $499.4 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 0.59% year-over-year to $499.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $499.4 million (up 0.59% YoY) and the FY2025 annual result came in at $497.0 million, up 0.51% from the prior year.
• Shares Outstanding (Entity) held at $499.4 million in Q1 2026 per ELAN's latest filing, from $497.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $499.4 million in Q1 2026 and troughed at $474.1 million in Q1 2022.
• A 5-year average of $490.0 million and a median of $494.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) climbed 0.23% in 2022, then increased 3.92% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $474.2 million in 2022, then advanced by 3.92% to $492.8 million in 2023, then advanced by 0.32% to $494.4 million in 2024, then grew by 0.51% to $497.0 million in 2025, then gained by 0.48% to $499.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $499.4 million, $497.0 million, and $496.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.